At-Home Telehealth-Supported Subcutaneous Ketamine Therapy for Safety, Feasibility, and Clinical Outcomes in Adults With Moderate to Severe Depression, Anxiety, or Posttraumatic Stress Disorder in a Large, Heterogeneous Cohort in the United States: Retrospective Cohort Study
Background: Depression, anxiety, and posttraumatic stress disorder (PTSD) are leading global causes of disability. Standard interventions have slow mechanisms of action, high attrition, and significant accessibility barriers. While intravenous and intranasal ketamine are rapid-acting alternatives, high cost and intensive logistical requirements limit adoption. Sublingual at-home ketamine addresses some gaps but is constrained by low bioavailability and variable absorption. Subcutaneous administr
Record details
Published: 20 July 2026
Source: JMIR (Journal of Medical Internet Research)
Category: Research
Topics: Healthcare
Retrieved: 21 July 2026
Related evidence
These records share source-supplied organisations, an exact publisher byline, automatic topics or regions. The reason is shown on every link; related does not mean supporting, agreeing with or verifying this record.
Communication Barriers in Patient-Provider Interactions in Health Care: Scoping Review
JMIR (Journal of Medical Internet Research) · 21 July 2026
From Spatial AI to Clinical Readiness: Lessons From Augmented World Expo USA 2026
JMIR (Journal of Medical Internet Research) · 17 July 2026
Federal Cuts and Public Health: Social Media Sentiment Among Federal Employees
JMIR (Journal of Medical Internet Research) · 15 July 2026
Perceived Importance of Abortion Care Features and Access to Telehealth Technologies Among Medication Abortion Patients by Abortion Care Model: Cross-Sectional Analysis of a Prospective Cohort Study
JMIR (Journal of Medical Internet Research) · 15 July 2026
Benchmarking the Safety of Large Language Models for Robotic Health Attendant Control
arXiv cs.CY · 27 July 2026
Moralizing metrics: Discourses of data and equity in California's public health response to COVID-19
Big Data & Society · 28 July 2026
How to cite this record
ethics.ai (20 July 2026), “At-Home Telehealth-Supported Subcutaneous Ketamine Therapy for Safety, Feasibility, and Clinical Outcomes in Adults With Moderate to Severe Depression, Anxiety, or Posttraumatic Stress Disorder in a Large, Heterogeneous Cohort in the United States: Retrospective Cohort Study,” evidence record 12047, https://ethics.ai/record/12047 (originally published by JMIR (Journal of Medical Internet Research)).
Use and limitations
This page is a stable index and citation surface for a source record. ethics.ai did not author the underlying report and has not independently verified every claim. Automatic topics may be imperfect. For consequential use, quote and cite the original publisher.